Report to head of UK equities Burville
IA launches review into equity income sector
Over the past decade, sector classification issues have proved a persistent thorn in the side of the Investment Association (and predecessor the IMA).
The pharmaceutical and biotechnology sector has performed well in recent years, primarily by virtue of attractive fundamentals.
Another UK Equity Income fund to be ejected
Firms asked if other income sectors require change
How have they performed?
One-year yield falling short of requirements